Cargando…
Paracetamol vs. Ibuprofen in Preterm Infants With Hemodynamically Significant Patent Ductus Arteriosus: A Non-inferiority Randomized Clinical Trial Protocol
Background: Currently, the first line treatment of persistent ductus arteriosus (PDA) is either indomethacin or ibuprofen. However, the potentially life-threatening side effects associated to their use have prompted physicians to look for alternative options. The incorporation of paracetamol as an a...
Autores principales: | García-Robles, Ana, Gimeno Navarro, Ana, Serrano Martín, María del Mar, Párraga Quiles, María José, Parra Llorca, Anna, Poveda-Andrés, José Luis, Vento Torres, Máximo, Aguar Carrascosa, Marta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7380081/ https://www.ncbi.nlm.nih.gov/pubmed/32766181 http://dx.doi.org/10.3389/fped.2020.00372 |
Ejemplares similares
-
Corrigendum: Paracetamol vs. Ibuprofen in Preterm Infants With Hemodynamically Significant Patent Ductus Arteriosus: A Non-inferiority Randomized Clinical Trial Protocol
por: García-Robles, Ana, et al.
Publicado: (2022) -
Oral paracetamol versus oral ibuprofen for treatment of patent ductus arteriosus
por: Al-lawama, Manar, et al.
Publicado: (2017) -
Intravenous paracetamol in comparison with ibuprofen for the treatment of patent ductus arteriosus in preterm infants: a randomized controlled trial
por: Dani, Carlo, et al.
Publicado: (2020) -
Paracetamol in Patent Ductus Arteriosus Treatment: Efficacious and Safe?
por: Bardanzellu, Flaminia, et al.
Publicado: (2017) -
Efficacy of paracetamol for the treatment of patent ductus arteriosus in preterm neonates
por: Terrin, Gianluca, et al.
Publicado: (2014)